These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12942120)

  • 21. Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy.
    Koda M; Kanczuga-Koda L; Sulkowska M; Surmacz E; Sulkowski S
    BMC Cancer; 2010 Jun; 10():320. PubMed ID: 20569445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment HIF-1α and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer.
    Havelund BM; Sørensen FB; Lindebjerg J; Spindler KL; Jakobsen A
    Anticancer Res; 2011 May; 31(5):1559-65. PubMed ID: 21617210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of glucose transporter-1 and -3 in the head and neck carcinoma--the correlation of the expression with the biological behaviors.
    Zhou S; Wang S; Wu Q; Fan J; Wang Q
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):189-94. PubMed ID: 18401196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of GLUT-1 in nasopharyngeal carcinoma and its clinical significance.
    Zhou JC; Zhang JJ; Zhang W; Ke ZY; Ma LG; Liu M
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4891-4895. PubMed ID: 29164572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical significance of p53, p21, and p27 expressions in rectal carcinoma.
    Lebe B; Sarioğlu S; Sökmen S; Ellidokuz H; Füzün M; Küpelioğlu A
    Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):38-44. PubMed ID: 15722792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy.
    García VM; Batlle JF; Casado E; Burgos E; de Castro J; Belda C; Barriuso J; Sánchez JJ; García-Cabezas MÁ; González-Barón M; Cejas P
    Colorectal Dis; 2011 Sep; 13(9):989-98. PubMed ID: 20718834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer.
    Wang Q; Chen ZG; Du CZ; Wang HW; Yan L; Gu J
    Histopathology; 2009 Sep; 55(3):284-93. PubMed ID: 19723143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membranous expression of glucose transporter-1 protein (GLUT-1) in embryonal neoplasms of the central nervous system.
    Loda M; Xu X; Pession A; Vortmeyer A; Giangaspero F
    Neuropathol Appl Neurobiol; 2000 Feb; 26(1):91-7. PubMed ID: 10736070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.
    Seeber LM; Horrée N; van der Groep P; van der Wall E; Verheijen RH; van Diest PJ
    BMC Cancer; 2010 Jun; 10():307. PubMed ID: 20565904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and prognostic value of glucose transporters and hexokinases in tonsil and mobile tongue squamous cell carcinoma.
    Deron P; Vermeersch H; Mees G; Vangestel C; Pauwels P; Van de Wiele C
    Histol Histopathol; 2011 Sep; 26(9):1165-72. PubMed ID: 21751148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia-related proteins in patients with rectal cancer undergoing neoadjuvant combined modality therapy.
    Lee-Kong SA; Ruby JA; Chessin DB; Pucciarelli S; Shia J; Riedel ER; Nitti D; Guillem JG
    Dis Colon Rectum; 2012 Sep; 55(9):990-5. PubMed ID: 22874607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The local immune phenotype influences prognosis in patients with nodal-positive rectal cancer after neoadjuvant chemoradiation.
    Schollbach J; Kircher S; Wiegering A; Anger F; Rosenwald A; Germer CT; Löb S
    Int J Colorectal Dis; 2020 Feb; 35(2):365-370. PubMed ID: 31828368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological implications of expressions of hypoxia-related molecules in esophageal superficial squamous cell carcinoma.
    Ogane N; Yasuda M; Shimizu M; Miyazawa M; Kamoshida S; Ueda A; Takata K; Sakuma Y; Miyagi Y; Kameda Y
    Ann Diagn Pathol; 2010 Feb; 14(1):23-9. PubMed ID: 20123453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer.
    Chikamoto A; Inoue R; Komohara Y; Sakamaki K; Hashimoto D; Shiraishi S; Takamori H; Yamashita YI; Yoshida N; Yamanaka T; Yamashita Y; Baba H
    Ann Surg Oncol; 2017 Jul; 24(7):2040-2046. PubMed ID: 28180987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microregional expression of glucose transporter-1 and oxygenation status: lack of correlation in locally advanced cervical cancers.
    Mayer A; Höckel M; Wree A; Vaupel P
    Clin Cancer Res; 2005 Apr; 11(7):2768-73. PubMed ID: 15814659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
    Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
    Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.
    Brown RS; Wahl RL
    Cancer; 1993 Nov; 72(10):2979-85. PubMed ID: 8221565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck.
    Reisser C; Eichhorn K; Herold-Mende C; Born AI; Bannasch P
    Int J Cancer; 1999 Jan; 80(2):194-8. PubMed ID: 9935199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability in glucose transporter-1 levels and hexokinase activity in human melanoma.
    Wachsberger PR; Gressen EL; Bhala A; Bobyock SB; Storck C; Coss RA; Berd D; Leeper DB
    Melanoma Res; 2002 Feb; 12(1):35-43. PubMed ID: 11828256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival.
    Schlößer HA; Drebber U; Urbanski A; Haase S; Baltin C; Berlth F; Neiß S; von Bergwelt-Baildon M; Fetzner UK; Warnecke-Eberz U; Bollschweiler E; Hölscher AH; Mönig SP; Alakus H
    Gastric Cancer; 2017 Jan; 20(1):83-91. PubMed ID: 26643879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.